Fremont, CA July 30, 2021 – Bionova Scientific, a biologics CDMO with deep process development expertise, announced today that Brad Larson has joined the company as Vice President of Manufacturing, Facilities and Engineering. Brad will be responsible for the launch and operation of Bionova’s new state-of-the-art single-use GMP biologics drug substance and drug product manufacturing facility.
Brad joins Bionova from Samsung Biologics in Incheon, South Korea. Prior to Samsung, Brad spent 22+ years with Jubilant HollisterStier (formerly Bayer Corporation then Hollister-Stier), a global CDMO.
Please see Brad’s profile on Bionova’s Leadership page.